Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Patch Test-Guided Type 4 Food Allergen Dietary Avoidance for Irritable Bowel Syndrome
NCT06288672 is registered in ClinicalTrials.gov with IBS-80, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Patch Test-Guided Type 4 Food Allergen Dietary Avoidance for Irritable Bowel Syndrome
- Lead sponsor
- IBS-80, LLC
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 15, 2023
- Completion date
- December 31, 2026
- Enrollment
- 250 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.